bromocriptine

(redirected from Bromocriptine mesylate)
Also found in: Medical, Encyclopedia.
Related to Bromocriptine mesylate: hyperprolactinemia, Cabergoline

bro·mo·crip·tine

 (brō′mō-krĭp′tēn)
n.
An ergot alkaloid, C32H40BrN5O5, that is a dopamine antagonist and is used in its mesylate form to treat Parkinson's disease, acromegaly, and excessive prolactin secretion, and to reduce the size of certain pituitary tumors.

[bromo- + (ergo)cryptine, an ergot alkaloid (from German Ergokryptin : Ergo(t), ergot + Greek kruptos, hidden; see cryptic + -in, -in).]

bromocriptine

(ˌbrəʊməʊˈkrɪptiːn)
n
a dopamine agonist drug which blocks the release of prolactin from the pituitary gland, used in the treatment of Parkinson's disease
Translations

bromocriptine

n bromocriptina
References in periodicals archive ?
Vero is seeking approval to market Cycloset(R), a patented novel oral formulation of bromocriptine mesylate, for the treatment of Type-2 Diabetes.
Food and Drug Administration has granted final approval for Mylan Pharmaceuticals' Abbreviated New Drug Application for Bromocriptine Mesylate Tablets USP, 2.
These include a patented formulation for bromocriptine mesylate, ranitidine tablets and capsules, and diclofenac sodium tablets.